IgG4-related disease (IgG4-RD) may involve multiple organs including pancreas, head and neck region, kidney, lung, retroperitoneum, and lymph node \[[@b1-jptm-2015-12-01]\]. Histologically, it is characterized by lymphoplasmacytic infiltration, storiform fibrosis and/or obliterative phlebitis with IgG4 immunohistochemical reactivity in plasma cells \[[@b2-jptm-2015-12-01]\]. In addition to histologic findings, serum IgG4 level is often elevated in patients with IgG4-RD \[[@b3-jptm-2015-12-01],[@b4-jptm-2015-12-01]\]. It is not difficult to diagnose IgG4-RD if an involved organ shows diffuse enlargement with an elevated serum IgG4 level. However, it may not be easy to suspect IgG4-RD if the lesion presents as a localized mass-forming lesion rather than diffuse organ involvement. Although localized mass-forming IgG4-related autoimmune pancreatitis has been reported occasionally \[[@b5-jptm-2015-12-01]-[@b7-jptm-2015-12-01]\], such manifestation in biliary tract has seldom been described in the literature. In addition, most reported biliary cases had simultaneous segmental involvement of bile duct wall as well as massforming lesions \[[@b8-jptm-2015-12-01]-[@b10-jptm-2015-12-01]\]. Here, we report a case of localized mass-forming IgG4-related cholangitis, which mimicked hilar cholangiocarcinoma and later progressed to multi-organ involving IgG4-related systemic autoimmune disease, with review of relevant literatures.

CASE REPORT
===========

A 61-year-old male, who had a past medical history of diabetes, coronary artery bypass surgery and idiopathic pulmonary disease, was admitted for the control of his blood sugar level. He complained of general weakness, easy fatigability, and weight loss of 3 kg for 10 days. Laboratory test results were within normal range except for elevated aspartate aminotransferase (100 U/L), alanine transaminase (114 U/L), and alkaline phosphatase (397 U/L). Although serum tumor markers were within normal limits (α-fetoprotein, 2 ng/mL; carcinoembryonic antigen, 1.56 ng/mL; carbohydrate antigen 19-9, 13.71 U/mL), additional tests for malignancy was conducted due to his weight loss. The magnetic resonance cholangiopancreatography disclosed a mass lesion at hilar bile duct. Magnetic resonance imaging (MRI) revealed a 2.1-cm-sized relatively well-demarcated mass at bifurcation of the left hepatic duct. The mass showed high signal intensity in diffusion restriction image and low intensity in apparent diffusion coefficient (ADC) map image, suggestive of type IV hilar cholangiocarcinoma with periductal invasion into underlying hepatic parenchyma ([Fig. 1A](#f1-jptm-2015-12-01){ref-type="fig"}, [B](#f1-jptm-2015-12-01){ref-type="fig"}). Since the patient had type 3 variation of intrahepatic bile duct-prior branching of right posterior Glisson pedicle which made the mass to be located apart from the right posterior duct, the lesion was considered to be resectable. Preoperative evaluation of positron emission tomography (PET) showed multiple enlarged lymph nodes in left axillary, common hepatic, portocaval, and aortocaval areas. Ultrasonography-guided biopsy of the axillary lymph node was performed; however, malignant cell was not identified, suggesting a reactive change rather than metastasis. Clinicians decided to perform surgery with an impression of hilar cholangiocarcinoma. A firm mass was detected at upper hilar level during the operation. Invasion to the left portal vein was suspected and the mass was also close to the right portal vein. Left trisectionectomy was performed for curative resection.

The resected specimen revealed a white firm mass-like lesion, measuring 2.5 × 2.0 × 1.3 cm, at bifurcation of the left intrahepatic bile duct ([Fig. 1C](#f1-jptm-2015-12-01){ref-type="fig"}). Histologic examination showed an extensive infiltration of lymphocytes and plasma cells ([Fig. 2A](#f2-jptm-2015-12-01){ref-type="fig"}). Storiform fibrosis was noted with a few foci of obliterative phlebitis ([Fig. 2B](#f2-jptm-2015-12-01){ref-type="fig"}). Immunohistochemical staining for IgG and IgG4 showed numerous IgG- and IgG4-immunoreactive plasma cells ([Fig. 2C](#f2-jptm-2015-12-01){ref-type="fig"}, [D](#f2-jptm-2015-12-01){ref-type="fig"}). The IgG4+ plasma cells were identified up to 53 cells per high-power field. IgG4+/IgG plasma cell ratio was 0.42. According to the consensus statement on the pathology of IgG4-RD, the lesion was diagnosed as "histologically highly suggestive of IgG4-RD \[[@b2-jptm-2015-12-01]\]."

Following the pathologic diagnosis of IgG4-RD, laboratory tests for serum IgG level was performed and it was within upper normal range in postoperative day 12 (1,522 mg/dL; reference range, 700 to 1,600 mg/dL). All subclasses of IgG were elevated: IgG1, 1,070 mg/dL (reference range, 341 to 894 mg/dL); IgG2, 694 mg/dL (reference range, 171 to 632 mg/dL); IgG3, 134 mg/dL (reference range, 11.5 to 105.3 mg/dL); and IgG4, 257 mg/dL (reference range, 2.4 to 121.0 mg/dL). Thorough investigation for involvement of other organs by IgG4-RD was done, but it failed to identify any additional abnormality. The patient did not receive corticosteroid treatment because no residual lesion was left after the resection and also because he was diabetic.

After a year, follow-up PET scan revealed an increased fluorodeoxyglucose (FDG) uptake in the biliary trees of right liver, pancreas, and perisplenic soft tissue as well as hypermetabolic lymphadenopathy involving supraclavicular, mediastinal, pulmonary hilar, subcarinal and left abdominal paraaortic lymph nodes, suggestive of progression to extrabiliary multi-organ IgG4-related autoimmune disease ([Fig. 3A](#f3-jptm-2015-12-01){ref-type="fig"}). Serum IgG level had also increased to 3,677 mg/dL, more than twice as high as the initial value. Fluorescent antinuclear antibody test showed 4+ result. The patient started to take prednisone once a day. However, computed tomography (CT) images after prednisone treatment for 6 months revealed subpleural consolidations and enlargement of mediastinal lymph nodes. As prednisone treatment was continued, the extent of subpleural consolidations diminished on the follow-up CT images. A year persistent treatment markedly decreased FDG uptake in bilateral supraclavicular, left axilla, mediastinal, subcarinal, pulmonary hilar, and retroperitoneal left paraaortic lymph nodes on PET scan, reflecting the patient's multi-organ IgG4-RD response to the steroid ([Fig. 3B](#f3-jptm-2015-12-01){ref-type="fig"}).

This study was approved by the Institutional Review Board of the Samsung Medical Center (IRB No. 2015-10-203).

DISCUSSION
==========

IgG4-RD was originally recognized in pancreas as autoimmune pancreatitis \[[@b11-jptm-2015-12-01]\]. Concomitant extrapancreatic manifestation is not uncommon in bile duct, lymph node, salivary glands, gastric mucosa, and kidney \[[@b1-jptm-2015-12-01],[@b3-jptm-2015-12-01],[@b12-jptm-2015-12-01]\]. Solitary organ involvement without pancreatitis has also been reported \[[@b1-jptm-2015-12-01],[@b3-jptm-2015-12-01],[@b4-jptm-2015-12-01]\]. IgG4-RD tends to present as diffuse lesion in the involved organs, especially in pancreas and biliary tract \[[@b13-jptm-2015-12-01]\]. Localized mass-forming autoimmune pancreatitis had frequently been misdiagnosed as malignancy and had resulted in unnecessary surgical resections \[[@b6-jptm-2015-12-01],[@b7-jptm-2015-12-01]\]. In contrast, mass-forming IgG4-related cholangitis is far less common and most reported cases were identified as long segment smooth narrowing of the bile ducts \[[@b14-jptm-2015-12-01]\]. [Table 1](#t1-jptm-2015-12-01){ref-type="table"} summarizes clinical, radiological and pathologic characteristics of localized mass-forming IgG4-related cholangitis cases that have been reported to date. Besides our case, all except one presented as hilar or intrahepatic mass accompanied by biliary stricture \[[@b8-jptm-2015-12-01]-[@b10-jptm-2015-12-01]\]. Since these lesions had often been misdiagnosed as cholangiocarcinoma, many patients had undergone unnecessary resection of liver. IgG4-RD could be diagnosed only after histopathologic examination of the resected specimen, which showed numerous IgG4+ plasma cell infiltrates \[[@b9-jptm-2015-12-01],[@b15-jptm-2015-12-01],[@b16-jptm-2015-12-01]\].

The case presented here clearly showed a mass lesion in both imaging studies and resected specimen without accompanying biliary stricture. Radiologists also had no doubt that the lesion was malignancy since it was not only a well-defined isolated mass but also it had characteristic features of malignant lesion in many imaging modalities; arterial phase of CT revealed enhancement and the lesion showed high signal intensity on diffusion restriction phase and low intensity on ADC map phase of MRI. Furthermore, the patient lost 3 kg of his weight for 10 days, a suspicious sign of malignancy. Multiple enlarged lymph nodes in our case were also regarded as metastasis from cholangiocarcinoma until the aspiration biopsy proved otherwise. Despite the negative result of aspiration biopsy of the lymph node, hilar cholangiocarcinoma was still suspected, considering the result as false-negative. However, a possibility of nodal manifestation of IgG4-RD should have been considered in this case because systemic nodal metastasis is an unusual finding for cholangiocarcinoma \[[@b17-jptm-2015-12-01]\].

Clinical diagnostic criteria to aid detection of IgG4-related sclerosing cholangitis were suggested by a Japanese group \[[@b18-jptm-2015-12-01]\]. The criteria included four items: (1) characteristic biliary imaging findings, (2) elevation of serum IgG4, (3) coexistence of other IgG4-related disease, and (4) histopathological features. To make definite diagnosis, thorough investigation of clinical, radiologic, laboratory and histopathologic examination is essential; however, all of these examinations are not always performed. Although there are some radiologic characteristics which help distinguish IgG4-related cholangitis from primary sclerosing cholangitis, it is still difficult to exclude hilar cholangiocarcinoma by image alone. Likewise, serum IgG4 level alone is not helpful since its sensitivity and specificity are not high \[[@b19-jptm-2015-12-01]\]. Some of IgG4-related cholangitis cases showed only minimally elevated serum IgG4 level \[[@b10-jptm-2015-12-01]\]. Histologic confirmation is necessary for definite diagnosis in this regard. Biopsy seems to be superior to brush cytology because some cases revealed false-positive atypical cells in brush cytology but resection specimen consisted of IgG4+ plasma cells and fibrosis only \[[@b20-jptm-2015-12-01]\]. Both quantity and quality of the biopsy are crucial for representing the entire lesion and immunohistochemical staining for IgG and IgG4 is required for an ac-curate diagnosis.

In summary, we report an unusual case of localized mass-forming IgG4-related cholangitis that mimicked hilar cholangiocarcinoma in the initial diagnostic approach. Since isolated mass-forming IgG4-RD without biliary stricture is extremely rare, exclusion of malignancy can be difficult without histopathologic confirmation. Also, the IgG4-related cholangitis in this patient later progressed to the most extensive form of systemic disease reported to date. Although IgG4-related cholangitis is rare, it should be considered in differential diagnosis of a solitary mass in the biliary tree that mimics cholangiocarcinoma, especially when it is accompanied by any evidence of systemic manifestation, including multiple lymphadenopathy and suspicious extrapancreatic organ involvement.
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![Magnetic resonance imaging reveals an enhancing mass lesion which has high signal intensity on diffusion restriction phase (A) and low intensity on apparent diffusion coefficient map phase (B), suspicious for malignancy. (C) The cut section of hilar bile duct shows a relatively well-demarcated mass-forming lesion with a hepatic parenchymal invasion.](jptm-2015-12-01f1){#f1-jptm-2015-12-01}

![Histologic examination reveals dense infiltration of lymphocytes and plasma cells (A) and storiform fibrosis (B). Both IgG-immunopositive (C) and IgG4-immunopositive (D) plasma cells are identified by immunohistochemical staining.](jptm-2015-12-01f2){#f2-jptm-2015-12-01}

![(A) Fluorodeoxyglucose (FDG) positron emission tomography--computed tomography, maximum intensity projection image show hypermetabolic lesions involving bilateral supraclavicular, left axillar, mediastinal, pulmonary hilar and retroperitoneal lymph nodes, right liver biliary tract, pancreas, and perisplenic area. (B) After steroid treatment, markedly decreased FDG uptake is noted although uptakes in some lymph nodes are still seen.](jptm-2015-12-01f3){#f3-jptm-2015-12-01}

###### 

Clinicopathological findings of previously reported cases of mass-forming IgG4-related cholangitis

  Reference                                    Sex   Age (yr)    Specimen type   Site                 Symptom                         Radiologic finding                                          IgG4 count (/HPF)                                      Sequence of biliary manifestation   Other manifestations                            Serum IgG4/IgG   Follow-up
  -------------------------------------------- ----- ----------- --------------- -------------------- ------------------------------- ----------------------------------------------------------- ------------------------------------------------------ ----------------------------------- ----------------------------------------------- ---------------- ----------------------
  Present case                                 M     61          Resection       Hilum                Fatigue, weight loss            Localized mass                                              45                                                     Initial                             Pancreas, pleura, LN, perisplenic soft tissue   257/1,522        Response on steroids
  Deshpande et al. \[[@b8-jptm-2015-12-01]\]   M     68          Biopsy          Liver and IBD        Jaundice                        Vague mass with alternate narrowing and dilatation of IBD   37                                                     Initial                             Salivary gland, retroperitoneum                 4,160/3,580      Response on steroids
  F                                            42    Resection   Hilum           Hepatic hilar mass   NA                              140                                                         Secondary                                              Pancreas                            NA                                              No steroid use   
  Hamano et al. \[[@b10-jptm-2015-12-01]\]     F     50          Biopsy          CBD                  Abdominal pain, jaundice        Mass with long CBD narrowing                                NA                                                     Initial                             No                                              122/1,711        Response on steroids
  Zen et al. \[[@b9-jptm-2015-12-01]\]         M     59          Resection       IBD                  NA                              Mass with irregular stricture                               +++^[a](#tfn1-jptm-2015-12-01){ref-type="table-fn"}^   Initial                             No                                              NA               NA
  M                                            79    Resection   IBD             NA                   Mass with irregular stricture   +++^[a](#tfn1-jptm-2015-12-01){ref-type="table-fn"}^        Initial                                                No                                  NA                                              NA               
  M                                            56    Resection   IBD             NA                   Mass with irregular stricture   +++^[a](#tfn1-jptm-2015-12-01){ref-type="table-fn"}^        Initial                                                LN                                  NA                                              NA               
  M                                            64    Resection   IBD             NA                   Mass with irregular stricture   +++^[a](#tfn1-jptm-2015-12-01){ref-type="table-fn"}^        Initial                                                LN                                  NA                                              NA               
  M                                            67    Resection   Left HD         NA                   Mass with irregular stricture   +++^[a](#tfn1-jptm-2015-12-01){ref-type="table-fn"}^        Initial                                                No                                  NA                                              NA               

HPF, high power field; M, male; LN, lymph node; IBD, intrahepatic bile duct; F, female; NA, not available; CBD, common bile duct; HD, hepatic duct.

The number of IgG4-immunopositive plasma cells is not counted; semiquantitative score is used instead.
